Core Laboratories Inc. (NYSE:CLB – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 6,340,000 shares, a growth of 16.5% from the November 30th total of 5,440,000 shares. Currently, 13.7% of the company’s stock are sold short. […]
StockNews.com upgraded shares of Core Laboratories (NYSE:CLB – Free Report) from a sell rating to a hold rating in a research report report published on Friday morning. Several other research analysts also recently weighed in on CLB. Citigroup cut their target price on shares of Core Laboratories from $21.00 to $20.00 and set a sell […]
Boston Trust Walden Corp lifted its stake in Core Laboratories Inc. (NYSE:CLB – Free Report) by 3.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,277,774 shares of the oil and gas company’s stock after buying an additional 79,166 shares during the quarter. Boston […]
Core Laboratories Inc. (NYSE:CLB – Get Free Report) dropped 1.7% during trading on Thursday . The stock traded as low as $18.09 and last traded at $18.11. Approximately 89,458 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 397,035 shares. The stock had previously closed at $18.42. Wall […]